Annual EBIT
-$100.26 M
+$2.50 M+2.44%
December 31, 2023
Summary
- As of February 7, 2025, OMGA annual earnings before interest & taxes is -$100.26 million, with the most recent change of +$2.50 million (+2.44%) on December 31, 2023.
- During the last 3 years, OMGA annual EBIT has fallen by -$71.59 million (-249.71%).
- OMGA annual EBIT is now -477.87% below its all-time high of -$17.35 million, reached on December 31, 2019.
Performance
OMGA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$16.42 M
+$160.00 K+0.97%
September 30, 2024
Summary
- As of February 7, 2025, OMGA quarterly earnings before interest & taxes is -$16.42 million, with the most recent change of +$160.00 thousand (+0.97%) on September 30, 2024.
- Over the past year, OMGA quarterly EBIT has increased by +$4.03 million (+19.71%).
- OMGA quarterly EBIT is now -214.32% below its all-time high of -$5.22 million, reached on March 31, 2020.
Performance
OMGA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$74.15 M
+$6.48 M+8.04%
September 30, 2024
Summary
- As of February 7, 2025, OMGA TTM earnings before interest & taxes is -$74.15 million, with the most recent change of +$6.48 million (+8.04%) on September 30, 2024.
- Over the past year, OMGA TTM EBIT has increased by +$20.74 million (+21.86%).
- OMGA TTM EBIT is now -1319.41% below its all-time high of -$5.22 million, reached on March 31, 2020.
Performance
OMGA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
OMGA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.4% | +19.7% | +21.9% |
| 3 y3 years | -249.7% | +19.7% | +21.9% |
| 5 y5 years | -477.9% | +19.7% | +21.9% |
OMGA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -51.8% | +2.4% | at high | +47.0% | -11.7% | +34.7% |
| 5 y | 5-year | -477.9% | +2.4% | -214.3% | +47.0% | -1319.4% | +34.7% |
| alltime | all time | -477.9% | +2.4% | -214.3% | +47.0% | -1319.4% | +34.7% |
Omega Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$16.42 M(-1.0%) | -$74.15 M(-8.0%) |
| Jun 2024 | - | -$16.58 M(-18.9%) | -$80.63 M(-15.0%) |
| Mar 2024 | - | -$20.45 M(-1.2%) | -$94.89 M(-5.4%) |
| Dec 2023 | -$100.26 M(-2.4%) | -$20.70 M(-9.6%) | -$100.26 M(-9.3%) |
| Sep 2023 | - | -$22.90 M(-25.7%) | -$110.53 M(-2.7%) |
| Jun 2023 | - | -$30.84 M(+19.5%) | -$113.61 M(+4.6%) |
| Mar 2023 | - | -$25.82 M(-16.6%) | -$108.62 M(+5.7%) |
| Dec 2022 | -$102.77 M | -$30.97 M(+19.2%) | -$102.77 M(+11.1%) |
| Sep 2022 | - | -$25.98 M(+0.5%) | -$92.46 M(+10.5%) |
| Jun 2022 | - | -$25.85 M(+29.5%) | -$83.70 M(+14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$19.96 M(-3.4%) | -$73.06 M(+10.1%) |
| Dec 2021 | -$66.03 M(+130.3%) | -$20.66 M(+20.0%) | -$66.38 M(+20.7%) |
| Sep 2021 | - | -$17.22 M(+13.1%) | -$54.99 M(+20.0%) |
| Jun 2021 | - | -$15.22 M(+14.6%) | -$45.81 M(+24.8%) |
| Mar 2021 | - | -$13.28 M(+43.2%) | -$36.72 M(+28.1%) |
| Dec 2020 | -$28.67 M(+65.2%) | -$9.27 M(+15.3%) | -$28.67 M(+47.8%) |
| Sep 2020 | - | -$8.04 M(+31.3%) | -$19.40 M(+70.9%) |
| Jun 2020 | - | -$6.13 M(+17.3%) | -$11.35 M(+117.3%) |
| Mar 2020 | - | -$5.22 M | -$5.22 M |
| Dec 2019 | -$17.35 M | - | - |
FAQ
- What is Omega Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Omega Therapeutics?
- What is Omega Therapeutics annual EBIT year-on-year change?
- What is Omega Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Omega Therapeutics?
- What is Omega Therapeutics quarterly EBIT year-on-year change?
- What is Omega Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Omega Therapeutics?
- What is Omega Therapeutics TTM EBIT year-on-year change?
What is Omega Therapeutics annual earnings before interest & taxes?
The current annual EBIT of OMGA is -$100.26 M
What is the all time high annual EBIT for Omega Therapeutics?
Omega Therapeutics all-time high annual earnings before interest & taxes is -$17.35 M
What is Omega Therapeutics annual EBIT year-on-year change?
Over the past year, OMGA annual earnings before interest & taxes has changed by +$2.50 M (+2.44%)
What is Omega Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of OMGA is -$16.42 M
What is the all time high quarterly EBIT for Omega Therapeutics?
Omega Therapeutics all-time high quarterly earnings before interest & taxes is -$5.22 M
What is Omega Therapeutics quarterly EBIT year-on-year change?
Over the past year, OMGA quarterly earnings before interest & taxes has changed by +$4.03 M (+19.71%)
What is Omega Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of OMGA is -$74.15 M
What is the all time high TTM EBIT for Omega Therapeutics?
Omega Therapeutics all-time high TTM earnings before interest & taxes is -$5.22 M
What is Omega Therapeutics TTM EBIT year-on-year change?
Over the past year, OMGA TTM earnings before interest & taxes has changed by +$20.74 M (+21.86%)